Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies

Area of Science:

• Regenerative Medicine
• Cell Biology
• Biotechnology

Background:

• Mesenchymal stem cells (MSCs) are crucial for regenerative medicine.
• Adipose tissue-derived stromal cells (ADSC) offer an alternative source of MSCs.
• ADSC possess comparable differentiation potential to bone marrow-derived MSCs.

Purpose of the Study:

• To review ADSC preparation, isolation, and molecular characterization.
• To summarize ADSC differentiation capacity into mesodermal lineages.
• To discuss ADSC mechanisms and future roles in cell therapy and tissue engineering.

Main Methods:

• Literature review focusing on ADSC preparation and differentiation.
• Analysis of molecular characterization data for ADSC.
• Discussion of current understanding and future directions for ADSC research.

Main Results:

• ADSC exhibit equal differentiation potential to bone marrow-derived MSCs into adipocytes, cartilage, bone, and skeletal muscle.
• Subcutaneous adipose tissue provides easier and more repeatable access for ADSC isolation.
• Initial efforts show potential for ADSC differentiation into non-mesodermal cell types, though mechanisms are unclear.

Conclusions:

• ADSC are a viable and advantageous alternative to bone marrow-derived MSCs for regenerative medicine.
• Understanding the molecular mechanisms governing ADSC lineage allocation is critical for advancing cell therapies.
• Further research into ADSC differentiation pathways will unlock their full therapeutic potential.